Recent Headlines
Within Pharmaceuticals
From Customer to CEO: Kaitlyn Talamante Acquires LadyBoss, the Women’s Health Brand Empowering Hundreds of Thousands Since 2014
LadyBoss, the women’s health and lifestyle brand founded in 2014 by Kaelin and Brandon Poulin, later sold to Russell Brunson in 2022, announces its new owner, Kaitlyn Talamante. A former LadyBoss customer turned CEO, Talamante’s journey from personal transformation to leading the brand represents a full-circle story of empowerment, growth, and vision for the future. - September 05, 2025 - LadyBoss
APTMetrics Welcomes Dr. Doug Reynolds and Dr. Matt Paese
APTMetrics, a talent management consultancy that enables organizations to unlock workforce and leadership potential through proven, AI-powered people science, announced today that Dr. Doug Reynolds and Dr. Matt Paese will be joining its leadership team. Dr. Reynolds will take on the role of... - September 04, 2025 - APTMetrics
GetReal Security Named Winner for Real-Time Threat Mitigation in the SiliconANGLE TechForward Awards
GetReal Security, the cybersecurity leader specialized in mitigating digital identity threats posed by malicious generative AI (GenAI) content, today announced it has been named the Real-Time Threat Mitigation Winner in SiliconANGLE’s inaugural 2025 TechForward Awards, and recognized as a... - August 26, 2025 - GetReal Security
Liminatus Pharma Announces Receipt of Nasdaq Listing Delinquency Letter
Liminatus Pharma, Inc. (Nasdaq: LIMN) (“Liminatus” or the “Company”), a pre-clinical stage biopharmaceutical company developing novel, immune-modulating cancer therapies, today announced that on August 22, 2025, it received a notification letter from Nasdaq indicating that... - August 26, 2025 - Liminatus Pharma, Inc
DDi added more AI Agents to enhance Regulatory Strategy, Planning, and Project Actions
DDi introduces AI Agents for Strategy, Planning, and Actions, including Regulatory Insights, Regulatory Impact, and Planning Agents. These tools provide compliance visibility, assess regulatory impacts, and optimize planning, enabling organizations to act with confidence and agility. - August 22, 2025 - DDi LLC
AcCELLerated Biologics to Distribute RegenaLase™ Laser System from IPG Medical Corporation Across the United States
AcCELLerated Biologics, LLC, a leading distributor of regenerative medicine technologies, today announced an exclusive agreement with IPG Medical Corporation, a wholly owned subsidiary of IPG Photonics Corporation, to distribute the RegenaLase™ Laser System throughout the United States. This... - August 20, 2025 - AcCELLerated Biologics
Co-Investigator of Clinical Safety Study Presents at EHA
Hemanext Inc., a leading innovator in blood processing, storage, and transfusion technology, announces that the data from its safety study was accepted in the form of an oral presentation at the European Hematology Association 2025 Congress that took place in Milan, Italy on June 12-15. - August 19, 2025 - Hemanext
CABRI Fellowship Program Opens for Undergraduate Research Applicants
The Cayman Biomedical Research Institute (CABRI) has announced that applications are now open for their undergraduate research fellowships. Applications may be submitted on the CABRI website from August 11, 2025 through September 29, 2025. - August 15, 2025 - Cayman Chemical Company
New Book “Life Lessons From the Overhead Bin: A Flight Attendant’s Advice on How to Be Fit, Fearless and Fulfilled After 50” Uplifts and Inspires Women to Soar in Midlife
In her debut book, author Helen Fritsch weaves observations and stories from her 40-year career in the sky with her unique inspirational advice and practical tips. - August 14, 2025 - Helen Fritsch
Peernovation Readiness Survey Now Available Online
By visiting Peernovation.biz/about and scrolling to the bottom, CEOs, HR professionals, and team leaders can now access a free, one-minute Peernovation Readiness Survey online. Peernovation helps leaders bring the proven best practices from CEO Forums to their organizations to create happier, higher-performing teams in this fast-changing world. - August 06, 2025 - Peernovation, LLC
Global Multiple Myeloma Therapeutics Market and Forecast to 2030
Apelo Consulting has released a report on Global Multiple Myeloma Therapeutics Market (By Disease, Treatment, Route of Administration, End User, Regional Analysis), Company Profiles, Market Dynamics and Recent Developments – Forecast to 2030. - July 31, 2025 - Apelo Consulting Pvt. Ltd.
YOLO Immune Inc. Emerges from Stealth Mode
YOLO Immune Inc. has emerged from stealth mode to unveil its human-centric drug discovery process and to announce the promotion of its founding research team. YOLO Immune is a venture-backed biotech company developing precision immunotherapies for the treatment of serious human diseases. The... - July 31, 2025 - YOLO Immune Inc
Ugandan Student Launches Hope.co.ug to Help People Ask Health Questions Online
Hope Emmanuel, a pharmacy student and tech enthusiast, has launched Hope.co.ug — a platform where Ugandans can ask health questions and receive clear, reliable answers in everyday language. - July 28, 2025 - Hope.co.ug
ERBESSD INSTRUMENTS Continues Global Expansion
ERBESSD INSTRUMENTS a global leader in dynamic balancing, vibration analysis, machinery health, and process health instrumentation and optimization announces expansion to Latin America. - July 25, 2025 - ERBESSD INSTRUMENTS
Hemanext Announces Close of Series B3 Equity Financing Round
Hemanext Inc., a leading innovator in blood processing, storage and transfusion technology, announced the close of its Series B-3 equity financing round. The round raised $18.9 million at a post-money valuation of $172 million or $0.275 per share, with support from new investors and repeat investments from those participating in the Series B-2 capital round. - July 22, 2025 - Hemanext
GENINVO Celebrates 8 Years of Innovation and Growth in the Life Sciences Industry
GENINVO, a leading provider of transformative digital solutions for the life sciences sector, proudly celebrates its 8th anniversary—a journey marked by innovation, collaboration, and impactful contributions across global healthcare and pharmaceutical domains. From a vision sparked eight... - July 22, 2025 - GenInvo, Inc.
Mind-Sync Launches Strategic Fundraising Round to Transform Long-Term Care Operations with AI-Driven Platform
Mind-Sync, an emerging leader in AI-powered healthcare technology, announced today the launch of a strategic fundraising round aimed at accelerating its mission to modernize operations in long-term care, assisted living, and memory care communities across the U.S. Mind-Sync’s founders... - July 19, 2025 - Mind-Sync, LLC
Enigma Networks Launches from Stealth to Deliver the First ZTNX Platform - Zero Trust for Internal Networks
Enigma Networks is pioneering ZTNX — Zero Trust for Internal Networks. Their agentless platform, Enigma AI, gives security teams real-time visibility into east-west traffic, discovers every asset, detects lateral movement, and enforces segmentation. Built for hybrid environments, Enigma AI eliminates internal blind spots and brings Zero Trust to where it’s needed most — inside the network. - July 15, 2025 - Enigma Networks Inc.
Phenotap, Inc. Receives Progr. Related Investment from Helmsley Charitable Trust to Advance Breakthrough Ketone Sensor Technology for People Living with Type 1 Diabetes
Phenotap, Inc. announced a $3 million investment to support the continued development and optimization of KetoTap™ Core, a novel enzymatic technology, to make it active and stable enough to be used as part of a continuous ketone sensor that can help prevent the occurrence of diabetic ketoacidosis (DKA) for people living with type 1 diabetes (T1D). - July 14, 2025 - Phenotap, Inc.
"RediPlate" Metabolism Assay Kits from AkrivisBio
AkrivisBio is thrilled to announce the launch of a new concept in assay kits, “RediPlate,” a patent pending design in which all the assay components are already applied to the wells. The end user has to merely rehydrate the well, add the sample and start reading. RediPlate kits are designed to enhance reproducibility, easy to use, and deliver faster, more accurate results. RediPlate kits are built to support your research work from discovery to validation. - July 14, 2025 - AkrivisBio
Aphora Health Acquires CareNexis to Accelerate Innovation in Specialty Pharmacy Benefits and AI-Driven Insights for Self-Insured Employers
Aphora Health, a leading provider of cost containment solutions and advanced pharmacy benefit strategies for self-insured employers, announces the acquisition of CareNexis, a digital health company known for its proprietary consumer health intelligence and engagement platform. This acquisition... - July 10, 2025 - Aphora Health
Precision Antibody to Attend and Present at Interphex Regenerative Medicine 2025 in Tokyo
Precision Antibody will attend Interphex Regenerative Medicine 2025 in Tokyo from July 9–11. Dr. Jun Hayashi will present on fully human antibody development, highlighting the company’s commitment to global collaboration and therapeutic innovation. - July 09, 2025 - Precision Antibody
Alera Bio Launches to Advance Breakthrough Therapies for Rare Neurological Disorders
Chicago-based Alera Bio has launched with a mission to develop treatments for ultra-rare and neglected neurological disorders, especially in children. Combining scientific innovation with patient urgency, the company will pursue both novel and repurposed therapies via orphan drug and 505(b)(2) pathways. With a lean, capital-efficient model, Alera Bio aims to rapidly advance therapies that address critical gaps in care. - July 03, 2025 - Alera Bio
DDi’s Visu Regulatory Platform Now with AI-Powered Project Management & Impact Assessment
DDi enhances its Visu platform with AI-driven project management tools, offering increased efficiency, real-time insights, and risk mitigation for pharma, biotech, and medical device industries. - June 29, 2025 - DDi LLC
New White Paper Maps the Real-World Adoption of AI in Healthcare and What It Means for Clinical Leaders and Innovators
“Crossing the Clinical Chasm: Unlocking the Value of AI in Healthcare” Spotlights Companies Delivering Measurable Value Through AI in Diagnostics, Trials, and Patient Care. This report answers a simple but urgent question: How to bridge the gap between innovation and adoption in healthcare? - June 27, 2025 - StratCraft, Inc.
Locus FS Announces Executive Appointments and Strategic Market Focus
Biotechnology company strengthens market position with new board and sharper commercial focus in oil & gas, mining, agriculture and industrial/CPG. - June 26, 2025 - Locus Fermentation Solutions
Liminatus Pharma Charts Dual-Front Attack on Cancer with IBA101
Next-generation CD47 inhibitor advances toward human trials in U.S. and Korea, with the prospect of safer, more potent immunotherapy. Since its Nasdaq debut earlier this year, Liminatus Pharma has been preparing to redefine the immune-oncology landscape with IBA101, a novel CD47 checkpoint... - June 24, 2025 - Liminatus Pharma, Inc
ALS TDI Announces New Agreement with Axol Bioscience to Expand Access to ALS Patient iPSC-Derived Cells for Global Research
The ALS Therapy Development Institute (ALS TDI) is proud to announce that a collection of cells derived from ALS patient-derived induced pluripotent stem cell (iPSC) lines will now be made widely available to researchers around the world. - June 24, 2025 - ALS Therapy Development Institute
MiglioreLaw Sees Drastic Increase in PFAS-Contaminated Water Cases on Long Island
MiglioreLaw is now accepting cases from Long Island residents diagnosed with Kidney, Testicular, Liver Cancer, and Ulcerative Colitis due to PFAS-contaminated drinking water. As local PFAS levels rise and awareness grows, the firm urges affected individuals to seek accountability. - June 24, 2025 - Rudolph FX Migliore PC
MtoZ Biolabs Launches Precision Chemical Proteomics Analysis Service
Chemical proteomics analysis service combines synthetic chemistry, cell biology, and mass spectrometry to profile small molecule–protein interactions for target identification, mechanism studies, and off-target evaluation. MtoZ Biolabs provides a one-stop chemical proteomics analysis service featuring Orbitrap MS, advanced probe design, and AI-driven analysis, supporting hit validation, candidate de-risking, and mechanistic research with high resolution and biological relevance. - June 20, 2025 - MtoZ Biolabs
New RNA Category: Self-Amplifiying RNAs (saRNAs) Are Now Available for a Longer Expression Period
Self-amplifying RNAs (saRNAs) also called “Replicons” are the next generation of RNA vaccines. Their advantage over conventional mRNA vaccine platforms relies on the viral replication machinery, which amplifies the mRNA of the encoded gene of interest within target cells. - June 20, 2025 - OZ Biosciences
Volunteers Gather at Scientology Church in Sacramento to Help Clean Streets in Recognition of World Environment Day
Scientologists and The Way To Happiness volunteers pass out the Way to Happiness booklets and clean up several blocks in downtown Sacramento. - June 19, 2025 - Church of Scientology of Sacramento
Hundreds of Cyclists to Ride Through Durham, NH, June 21–22, to Raise Funds for ALS Research
On June 21, hundreds of cyclists will ride through Durham, NH, as part of the Tri-State Trek—New England’s premier ALS fundraising bike ride. This inspiring event raises critical funds for the ALS Therapy Development Institute, a nonprofit biotech leading the charge in developing effective treatments for ALS. The Trek brings together local families, riders, and volunteers in a powerful show of support for those living with this devastating disease. - June 16, 2025 - ALS Therapy Development Institute
Fantastic Nutrition Launches Creatine Fantastic, a Science-Based Supplement Featuring Creatine and myHMB® for Enhanced Muscle Strength and Recovery
Research shows that combining creatine with myHMB can increase lean muscle mass up to 30% more than creatine alone (Wilson et al., 2014, Journal of the International Society of Sports Nutrition). This blend not only helps build muscle and recover faster, but also reduces muscle degradation, enhances athletic performance, and supports cognitive function—a total performance formula for both body and mind. - June 15, 2025 - Fantastic Nutrition
The Integritus Group a Division of SEMM Holdings Launches XceptView: Video Intelligence Built for Independent Retail, Food & Beverage, and Convenience Store Operators
SEMM Holdings, a trusted leader in operational excellence, compliance, and profit protection, today announced the launch of XceptView, a powerful new solution tailored to the needs of independent retailers, hospitality businesses, and convenience store owners. - June 11, 2025 - SEMM Holdings
3rd Annual ALS 100 Hole Challenge Set for June 17, 2025, in Hartford, CT
On Tuesday, June 17, 2025, twenty-four passionate golfers will take on a marathon challenge—playing 100 holes of golf in a single day—to raise critical funds and awareness in the fight against ALS. The third annual ALS 100 Hole Challenge will take place at Keney Park Golf Course in... - June 09, 2025 - ALS Therapy Development Institute
SEMM Holdings and Sharpvue Announce Strategic Partnership to Transform Operational Excellence and Surveillance Innovation
SEMM Holdings, a trusted leader in operational excellence through compliance, safety, and profit protection, today announced a strategic partnership with Sharpvue, a top innovator in mobile AI surveillance and commercial cloud video technology. This collaboration brings together deep domain expertise in asset protection, operational compliance and advanced surveillance technology to help organizations elevate safety, reduce risk, and increase operational transparency across industries. - June 06, 2025 - SEMM Holdings
H3Tech Welcomes Ruiban Coutinho as AI Healthtech Consultant
H3Tech, a healthcare technology and consulting firm, has appointed Ruiban Coutinho as AI Healthtech Consultant. With 14 years of experience in data analytics and business intelligence, Coutinho will leverage his expertise in AI, SAP BW/HANA, and Power BI to enhance H3Tech’s AI-driven healthcare solutions. - June 06, 2025 - H3Tech
Liminatus Pharma Announces Compliance with Nasdaq Filing Requirements
Liminatus Pharma, Inc. (Nasdaq: LIMN) (“Liminatus” or the “Company”), a pre-clinical stage biopharmaceutical company developing novel, immune-modulating cancer therapies, today announced that on June 3, 2025, it received a notification letter from Nasdaq indicating that it... - June 04, 2025 - Liminatus Pharma, Inc
Anzor Pharmaceuticals to Present at Chronic Kidney Disease Conference
Fibroblast growth factor technology constitutes a significant breakthrough in the treatment of metabolic and cancer-related diseases. - June 03, 2025 - Anzor Pharmaceuticals
Scientology Volunteer Ministers Reach Out with Practical Solutions at Kids Day in Sacramento
The Volunteer Ministers of the Sacramento Church of Scientology reach out at local community event to help families and children offering free on line courses for common everyday problems. - May 29, 2025 - Church of Scientology of Sacramento
No Collars, No Limits: HALO Chip Brings Real-Time GPS Tracking Under the Skin
HALO Technologies, Inc. has developed an implantable GPS microchip for pets and wildlife. Now in pre-launch, The HALO Chip offers discreet, real-time tracking without external devices. - May 28, 2025 - Halo Technologies Inc
Good Mana Knows the Secret to Powerful Health Benefits: ʻŌlena Gold Turmeric - A Premium Organic Supplement Grown in Nutrient-Dense Hawaiian Soil
Good Mana, based in Waimanalo, Hawai'i, is raising the industry standard for potency, purity and traceability of turmeric supplements with its premium ʻŌlena Gold Turmeric brand. - May 24, 2025 - Good Mana
Mindful Connections Therapy Announces New Ketamine Assisted Psychotherapy Services in Tucson, AZ
Mindful Connections Therapy, a leading provider of mental health services in Tucson Arizona, is proud to announce the launch of its new Ketamine Assisted Therapy services. This innovative treatment option offers a promising path to healing for individuals struggling with depression, trauma, and anxiety, providing a unique approach to mental wellness. - May 24, 2025 - Mindful Connections Therapy
Community Health Provider Aims to Make Health Care More Accessible
Affordable Behavioral Health Care is Hard to Find in Smaller, Underserved Communities. - May 23, 2025 - Total Point Healthcare
Phytobiosomes by Costas Picadas
Henri Dunant Hospital proudly presents Costas Picadas: Phytobiosomes, a unique exhibition of prints and digital installations that opened on Monday, May 19, 2025, and runs through Tuesday, September 30, 2025. The internationally recognized New York-based art historian Dr. Thalia Vrachopoulos curated the exhibition. - May 22, 2025 - Costas Picadas
Hemanext Welcomes New Member to Board of Directors
Geoff Crouse, an esteemed professional with over 25 years of leadership in the life sciences sector, joins the visionary leadership team guiding Hemanext’s mission to elevate the standard of care for patients who depend on transfusions. - May 21, 2025 - Hemanext
The New Gods of Medicine Summit Debuts in Cannes This June
Longevity Docs Presents: The New Gods of Medicine Summit Debuts in Cannes This June. - May 21, 2025 - Longevity Docs
Samantha's Outings Acquires First Transportation Van to Expand Services for Young Adults with Special Needs
After school ends, so do many of the support services available to individuals with special needs — leaving families facing an uncertain future. Samantha’s Outings, a San Diego-based nonprofit, is working to fill that critical gap. Today, the organization proudly announces the... - May 18, 2025 - Samantha's Outings
New QualiFam Autism Protocol Now Available in U.S. Treats Root Biological Causes Behind Symptoms
Developed by physician-scientist Dr. Ken Alibek, the QualiFam Protocol delivers results in as little as three months by targeting immune and infection-linked triggers. - May 16, 2025 - QualiFam